Former Netchemia CEO, KC venture capitalist launch new fund for Midwest software firms
February 1, 2018 | Bobby Burch
Keith Harrington isn’t looking for hockey-stick growth companies.
With the new fund he’s co-leading — Novel Growth Partners — Harrington wants to invest in small, steadily-growing tech companies in the Midwest. But instead of a traditional venture capital model, Novel is employing a revenue-based finance model that should appeal to more entrepreneurs, Harrington said.
“We believe that the current financing ecosystem excludes the majority of companies seeking financing. We know that only a small percentage of companies get venture capital and most young companies are too small for private equity and can’t get meaningful bank financing,” said Harrington, a former managing director at Kansas Bioscience Authority and recent Kauffman Fellow graduate. “We also recognize that there is a very large set of early-stage companies with revenue and growth that can benefit from the unique combination of capital and operational expertise we deploy.”
Harrington partnered with former Netchemia CEO Carlos Antequera to launch the fund. Antequera’s former firm sold to Vista Equity Partners in 2015.
With decades of business experience, the duo was inspired by challenges they recognized in firms’ ability to attract the appropriate type of funding — particularly in markets with limited access early-stage capital.
Here’s how Novel’s royalty-like model works:
Instead of taking portfolio company’s equity — thus requiring it to sell to generate a large return on the investment — Novel’s investment gets paid back at a set monthly percentage of the company’s revenue. The percentage is usually between 4 and 8 percent of the portfolio firm’s monthly revenue up to a predetermined return cap of up to five years. Novel provides developing software companies $100,000 to $500,000 in growth capital.
As a result, the entrepreneur is able to preserve ownership while growing the value of the company.
Novel plans to further add value to its portfolio firms by offering a boot camp focused on identifying and executing specific projects to accelerate revenue growth, Antequera said. During the boot camp, Novel props up new systems, automates processes and helps identify talent that will accelerate sales, Antequera said.
“We’re on a mission to provide capital to companies that have some revenue, customers and are focused on improving their business fundamentals, but in addition to capital, need improved sales systems, processes and talent to grow,” said Antequera. “Because venture requires rapid scaling, it is not the right type of capital for many companies. Equity venture investors cannot fund slow-growth opportunities. That’s where we come in, our model allows us to provide capital to companies with steady growth.”
Featured Business

2018 Startups to Watch
stats here
Related Posts on Startland News
Events Preview: Conquer for Good, TEDxUMKC
There are a plethora of entrepreneurial events hosted in Kansas City on a weekly basis. Whether you’re an entrepreneur, investor, supporter, or curious community member — we recommend these upcoming events for you. Are you hosting a relevant community event? Feel free to add it to the FWD/KC calendar for increased exposure. Once your event…
Jaguar Land Rover invests in artificial intelligence startup Mycroft
Mycroft has received a significant boost in horsepower. Only a few weeks after entering 500 Startups, Mycroft has landed a strategic partnership with Jaguar Land Rover. The Kansas City-based artificial intelligence startup is among the first startups to enter the Portland-based Jaguar Land Rover Tech Incubator, which will provide Mycroft with a $110,000 investment and…
KC-based OYO Fitness closes a historically successful Kickstarter
To say that OYO Fitness has a successful Kickstarter campaign would be an understatement. The Kansas City-based fitness firm folded up and then crushed its recent crowdfunding effort, which raised a stunning $659,000 for its collapsible and compact exercise device. OYO’s DoubleFlex Black campaign — which snagged pre-orders from 4,200 backers — was the second…
Survivor, innovator Kim Gandy rewards patients for sticking to treatments
In her 20 years working as a transplantation clinician, Kim Gandy found it baffling that a seemingly simple problem had such a difficult time finding a solution. Transplant patients consistently struggled to adhere to their health regimens, resulting not only in significant costs for care providers but also death. “We were literally losing patients,” Gandy…
